Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Change in Acquisitions & Divestments (2022 - 2026)

Insmed's Change in Acquisitions & Divestments history spans 8 years, with the latest figure at $284.0 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 60.61% to $284.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Mar 2026, up 15.03% year-over-year, with the annual reading at $2.1 billion for FY2025, 105.71% up from the prior year.
  • Change in Acquisitions & Divestments came in at $284.0 million for Q1 2026, down from $436.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $721.0 million in Q1 2025 to a low of $10.0 million in Q3 2023.
  • The 5-year median for Change in Acquisitions & Divestments is $300.0 million (2023), against an average of $295.4 million.
  • The largest YoY upside for Change in Acquisitions & Divestments was 1100.0% in 2023 against a maximum downside of 80.0% in 2023.
  • Insmed's Change in Acquisitions & Divestments stood at $25.0 million in 2022, then soared by 1100.0% to $300.0 million in 2023, then surged by 138.67% to $716.0 million in 2024, then plummeted by 39.11% to $436.0 million in 2025, then crashed by 34.86% to $284.0 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Change in Acquisitions & Divestments are $284.0 million (Q1 2026), $436.0 million (Q4 2025), and $425.0 million (Q3 2025).